Independent Advisor Alliance Adma Biologics, Inc. Transaction History
Independent Advisor Alliance
- $3.36 Billion
- Q2 2025
A detailed history of Independent Advisor Alliance transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 115,563 shares of ADMA stock, worth $1.69 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
115,563
Previous 89,475
29.16%
Holding current value
$1.69 Million
Previous $1.78 Million
18.54%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
402Shares Held
197MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$272 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86.3 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...